Cargando…

AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells

Lung carcinoma is the most common type of cancer and the leading cause of cancer-related death worldwide. Among the numerous therapeutic strategies for the treatment of lung cancer, adeno-associated virus (AAV)-mediated gene transfer has been demonstrated to have the potential to effectively suppres...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bin, Li, Zhiqing, Huang, Shi, Yan, Biying, He, Shan, Chen, Fengyuan, Liang, Yaxuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414974/
https://www.ncbi.nlm.nih.gov/pubmed/34485293
http://dx.doi.org/10.3389/fcell.2021.707607
_version_ 1783747883668865024
author Liu, Bin
Li, Zhiqing
Huang, Shi
Yan, Biying
He, Shan
Chen, Fengyuan
Liang, Yaxuan
author_facet Liu, Bin
Li, Zhiqing
Huang, Shi
Yan, Biying
He, Shan
Chen, Fengyuan
Liang, Yaxuan
author_sort Liu, Bin
collection PubMed
description Lung carcinoma is the most common type of cancer and the leading cause of cancer-related death worldwide. Among the numerous therapeutic strategies for the treatment of lung cancer, adeno-associated virus (AAV)-mediated gene transfer has been demonstrated to have the potential to effectively suppress tumor growth or reverse the progression of the disease in a number of preclinical studies. AAV vector has a safety profile; however, the relatively low delivery efficacy to particular subtypes of lung carcinoma has limited its prospective clinical translation. Exosomes are nanosized extracellular vesicles secreted from nearly all known cell types. Exosomes have a membrane-enclosed structure carrying a range of cargo molecules for efficient intercellular transfer of functional entities, thus are considered as a superior vector for drug delivery. In the present study, we developed a novel strategy to produce and purify AAV-containing exosomes (AAVExo) from AAV-packaging HEK 293T cells. The cellular uptake capacity of exosomes assisted and enhanced AAV entry into cells and protected AAV from antibody neutralization, which was a serious challenge for AAV in vivo application. We tested a list of lung cancer cell lines representing non-small-cell lung cancer and small-cell lung cancer and found that AAVExo apparently improved the gene transfer efficiency compared to conventional AAV vector. Our in vitro results were supported in vivo in a lung cancer xenograft rodent model. Additionally, we evaluated the gene delivery efficiency in the presence of neutralizing antibody on lung cancer cells. The results demonstrated that AAVExo-mediated gene transfer was not impacted, while the AAV vectors were significantly blocked by the neutralizing antibody. Taken together, we established an efficient methodology for AAVExo purification, and the purified AAVExo largely enhanced gene delivery to lung cancer cells with remarkable resistance to antibody neutralization.
format Online
Article
Text
id pubmed-8414974
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84149742021-09-04 AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells Liu, Bin Li, Zhiqing Huang, Shi Yan, Biying He, Shan Chen, Fengyuan Liang, Yaxuan Front Cell Dev Biol Cell and Developmental Biology Lung carcinoma is the most common type of cancer and the leading cause of cancer-related death worldwide. Among the numerous therapeutic strategies for the treatment of lung cancer, adeno-associated virus (AAV)-mediated gene transfer has been demonstrated to have the potential to effectively suppress tumor growth or reverse the progression of the disease in a number of preclinical studies. AAV vector has a safety profile; however, the relatively low delivery efficacy to particular subtypes of lung carcinoma has limited its prospective clinical translation. Exosomes are nanosized extracellular vesicles secreted from nearly all known cell types. Exosomes have a membrane-enclosed structure carrying a range of cargo molecules for efficient intercellular transfer of functional entities, thus are considered as a superior vector for drug delivery. In the present study, we developed a novel strategy to produce and purify AAV-containing exosomes (AAVExo) from AAV-packaging HEK 293T cells. The cellular uptake capacity of exosomes assisted and enhanced AAV entry into cells and protected AAV from antibody neutralization, which was a serious challenge for AAV in vivo application. We tested a list of lung cancer cell lines representing non-small-cell lung cancer and small-cell lung cancer and found that AAVExo apparently improved the gene transfer efficiency compared to conventional AAV vector. Our in vitro results were supported in vivo in a lung cancer xenograft rodent model. Additionally, we evaluated the gene delivery efficiency in the presence of neutralizing antibody on lung cancer cells. The results demonstrated that AAVExo-mediated gene transfer was not impacted, while the AAV vectors were significantly blocked by the neutralizing antibody. Taken together, we established an efficient methodology for AAVExo purification, and the purified AAVExo largely enhanced gene delivery to lung cancer cells with remarkable resistance to antibody neutralization. Frontiers Media S.A. 2021-08-13 /pmc/articles/PMC8414974/ /pubmed/34485293 http://dx.doi.org/10.3389/fcell.2021.707607 Text en Copyright © 2021 Liu, Li, Huang, Yan, He, Chen and Liang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Liu, Bin
Li, Zhiqing
Huang, Shi
Yan, Biying
He, Shan
Chen, Fengyuan
Liang, Yaxuan
AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells
title AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells
title_full AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells
title_fullStr AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells
title_full_unstemmed AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells
title_short AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells
title_sort aav-containing exosomes as a novel vector for improved gene delivery to lung cancer cells
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414974/
https://www.ncbi.nlm.nih.gov/pubmed/34485293
http://dx.doi.org/10.3389/fcell.2021.707607
work_keys_str_mv AT liubin aavcontainingexosomesasanovelvectorforimprovedgenedeliverytolungcancercells
AT lizhiqing aavcontainingexosomesasanovelvectorforimprovedgenedeliverytolungcancercells
AT huangshi aavcontainingexosomesasanovelvectorforimprovedgenedeliverytolungcancercells
AT yanbiying aavcontainingexosomesasanovelvectorforimprovedgenedeliverytolungcancercells
AT heshan aavcontainingexosomesasanovelvectorforimprovedgenedeliverytolungcancercells
AT chenfengyuan aavcontainingexosomesasanovelvectorforimprovedgenedeliverytolungcancercells
AT liangyaxuan aavcontainingexosomesasanovelvectorforimprovedgenedeliverytolungcancercells